Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysisKazem Rahimi, Barry R. Davis, Takayoshi Ohkubo et al.|The Lancet|2021Cited by 997
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)Isao Taguchi, Ryozo Nagai, Satoshi Iimuro et al.|Circulation|2018Cited by 242
Angiotensin Ⅱ Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4Susumu Matsuda, Masunori Matsuzaki|Journal of Atherosclerosis and Thrombosis|2015Cited by 67
TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: the roles of extracellular SOD and NADPH oxidaseTadaaki Nakashima, Masunori Matsuzaki|Hypertension Research|2015Cited by 57
B112 Study on Analyzing Technique of Tissue Light Propagation using FDTD MethodMasayuki Yamamoto, Masunori Matsuzaki|Baiofurontia Kouenkai kouen rombunshuu/Baiofurontia Koenkai koen ronbunshu|2005Cited by 0